Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplant

Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients

Related Keywords

New York ,United States ,France ,San Francisco ,California ,Philadelphia ,Pennsylvania ,American ,Dixon Kaufman ,Patrick Rossignol ,Daniel Brennan ,American Society Of Nephrology Kidney Week ,Uw Health Transplant Center ,University Of Wisconsin ,American Society ,Kidney Week ,Therapy Eases Need ,Immunosuppressive Drugs After ,Medeor Therapeutics ,Transplant Center ,Diabetic Kidney ,High Risk Hemodialysis ,New York City ,